BioCryst Pharmaceuticals
BCRX
#4925
Rank
C$2.52 B
Marketcap
C$10.19
Share price
-0.40%
Change (1 day)
-22.15%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - P/B ratio

P/B ratio as of February 2026 : -4.77

According to BioCryst Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 3.08283.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioCryst Pharmaceuticals - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31-4.0721.43%
2024-12-31-3.3624.59%
2023-12-31-2.69-62.93%
2022-12-31-7.26-68.81%
2021-12-31-23.3-65.89%
2020-12-31-68.3-591.41%
2019-12-3113.9-22.97%
2018-12-3118.0212.76%
2017-12-315.77-98.05%
2016-12-312961765.24%
2015-12-3115.937.12%
2014-12-3111.6-102.9%
2013-12-31-399150.56%
2012-12-31-159-2210.4%
2011-12-317.54112.56%
2010-12-313.557.92%
2009-12-313.29191.24%
2008-12-311.13-68.77%
2007-12-313.62-77.38%
2006-12-3116.093.53%
2005-12-318.2692.63%
2004-12-314.29-0.37%
2003-12-314.30918.74%
2002-12-310.4224

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Gilead Sciences
GILD
8.76-283.86%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
5.66-218.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
1.47-130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
3.72-178.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-9.67 102.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
2.55-153.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
3.07-164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
2.49-152.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
1.02-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA